Agilent Technologies (A) 38.27 $A
Agilent's Mixed Q4 Report Yields Mixed Reactions
at Investor's Business Daily - 2 hrs 17 mins ago
Scientific instrument maker Agilent Technologies (A) opened down but quickly rose in heavy volume Tuesday after it beat Q4 estimates late Monday but offered guidance below consensus, leading to dueling analyst actions. For its fiscal Q4 ended Oct....
A: 38.27 (+0.94)
Agilent Technologies Beats Q4 Earnings, Matches Revenues
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 8:20AM CST
Agilent Technologies' (A) fiscal fourth-quarter 2015 earnings per share of 50 cents beat the Zacks Consensus Estimate by 3 cents and came above management's guidance range.
AMZN: 643.63 (-4.18), A: 38.27 (+0.94), TVPT: 13.73 (-0.03), STMP: 95.21 (-0.23)
Agilent Technologies (A) Earnings Report: Q4 2015 Conference Call Transcript
at The Street - Tue Nov 17, 7:15AM CST
The following Agilent Technologies (A) conference call took place on November 16, 2015, 04:30 PM ET. This is a transcript of that earnings call:
A: 38.27 (+0.94)
World Flow Cytometry Market Opportunities and Forecasts 2014-2022
M2 - Tue Nov 17, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/6sgk45/_world_flow) has announced the addition of the " World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022" report to their offering. The world flow cytometry market is estimated to reach $7.0 billion by 2022, registering a CAGR of 16.0% over the forecast period Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices. The flow cytometry technology is widely used in the various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV and hematological malignancies. Rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need of flow cytometry in the effective diagnosis and monitoring of diseases. World flow cytometry market is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics and marine biology would further supplement the market growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users and the limited availability of technical expertise are likely to impede the market growth. The preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 World Flow Cytometry Market, By Component, 2014-2022 Chapter 5 World Flow Cytometry Market, By Technology, 2014-2022 Chapter 6 World Flow Cytometry Market, By Application, 2014-2022 Chapter 7 World Flow Cytometry Market, By End User, 2014-2022 Chapter 8 World Flow Cytometry Market, By Geography, 2014-2022 Chapter 9 Company Profiles - Affymetrix Inc. - Becton - Bio-Rad Laboratories - Dako (Agilent Technologies) - Danaher Corporation (Beckman Coulter) - Dickinson and Co. - Luminex Corporation - Merck Millipore - Miltenyi Biotec GmbH. - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/6s...world_flow
A: 38.27 (+0.94), MRK: 53.66 (-0.04), LMNX: 20.71 (-0.03), DHR: 95.27 (+0.12), AFFX: 8.99 (+0.07)
Agilent Technologies Reports Fourth-Quarter 2015 Results
M2 - Tue Nov 17, 2:26AM CST
Highlights:
A: 38.27 (+0.94)
How Will Agilent Technologies (A) Stock React to Earnings Beat?
at The Street - Mon Nov 16, 3:42PM CST
After the market close, Agilent Technologies (A) reported 2015 fourth quarter earnings ahead of expectations, while revenue was in line with estimates.
A: 38.27 (+0.94)
U.S. Cancer Diagnostics Market 2016: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
M2 - Mon Nov 16, 10:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/74t673/2016_u_s_cancer) has announced the addition of the "2016 U.S. Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. This new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Business Opportunities and Strategic Recommendations - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. Market Segmentation Analysis - Sales and market shares of major suppliers, by individual cancer diagnostic test. Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including: - Hospitals - Commercial/Private Laboratories - Physician Offices/Group Practices - Cancer Clinics - Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers. - Cancer statistics, etiology and recent developments. Current and Emerging Products Review of over 200 current and emerging cancer diagnostic tests, including: - Biochemical Markers - Oncogenes - Growth Factors - Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains, and others. - Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/74...u_s_cancer
SQNM: 1.64 (-0.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), DGX: 67.96 (+0.45), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
Global Cancer Diagnostics Market 2016: Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers
M2 - Mon Nov 16, 10:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/8jj4mk/2016_global) has announced the addition of the "2016 Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers" report to their offering. This new report provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: - Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, UK and US - Marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others - Overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new technologies, products, and applications - Review of current instrumentation used for cancer diagnostic testing - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing - Competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy - Profiles of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/8j...016_global
MYGN: 43.45 (+1.03), A: 38.27 (+0.94), DGX: 67.96 (+0.45), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12)
2016 Global Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants
M2 - Mon Nov 16, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/l2f5q9/2016_global) has announced the addition of the "2016 Global Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants" report to their offering. This new report provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/l2...016_global
SQNM: 1.64 (-0.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), DGX: 67.96 (+0.45), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
World Beta-2 Microglobulin Testing Market Report 2016-2021 - Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies & Competitive Landscape
M2 - Mon Nov 16, 6:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/3zh7zg/2016_world_beta2) has announced the addition of the "2016 World Beta-2 Microglobulin Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-- US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. This report presents a detailed analysis of the ?-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco For more information visit http://www.researchandmarkets.com/research/3z...orld_beta2
MYGN: 43.45 (+1.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
2016-2021 World CA Tumor Markers Testing Market Report
M2 - Mon Nov 16, 6:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/z2jn8v/2016_world_ca) has announced the addition of the "2016 World CA Tumor Markers Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. This report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/z2...6_world_ca
SQNM: 1.64 (-0.03), A: 38.27 (+0.94), DGX: 67.96 (+0.45), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12)
2016 World CEA Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies & Competitive Landscape
M2 - Mon Nov 16, 6:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/ksfml4/2016_world_cea) has announced the addition of the "2016 World CEA Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/ks..._world_cea
SQNM: 1.64 (-0.03), MYGN: 43.45 (+1.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), CPHD: 35.31 (+0.22), HOLX: 39.90 (+0.17)
2016 World Occult Blood Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape
M2 - Mon Nov 16, 6:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/htwtlc/2016_world_occult) has announced the addition of the "2016 World Occult Blood Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. This report presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/ht...rld_occult
SQNM: 1.64 (-0.03), MYGN: 43.45 (+1.03), A: 38.27 (+0.94), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
Nov. 16 Premarket Briefing: Marriott to Buy Starwood
at The Street - Mon Nov 16, 6:00AM CST
U.S. stock futures rise Monday, while European stocks are mixed in choppy trading following the terrorist attacks in Paris on Friday that left at least 129 people dead.
GE: 30.02 (-0.34), CCL: 50.47 (-0.30), A: 38.27 (+0.94), PFE: 33.01 (-0.15), MAR: 73.36 (-0.36), HOT: 72.25 (-0.02), DDS: 72.96 (+0.44), URBN: 21.00 (-1.67), AGN: 296.11 (-2.60), ERIC: 9.48 (-0.06), CAT: 69.44 (-0.95), JD: 28.82 (+0.01), CSCO: 26.85 (+0.06)
What Lies Ahead for Agilent Technologies' (A) Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 12:40PM CST
Agilent Technologies Inc. (A) is set to report fourth-quarter fiscal 2015 results on Nov 16. Last quarter, the company posted a 7.32% positive earnings surprise.
STOR: 21.87 (+0.09), A: 38.27 (+0.94), SDLP: 10.69 (-0.44), SIG: 137.05 (-1.60)
Global Mass Spectrometry Market 2015-2019
M2 - Thu Nov 12, 8:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkntz7/global_mass) has announced the addition of the "Global Mass Spectrometry Market 2015-2019" report to their offering. The global mass spectrometry market to grow at a CAGR of 8.34% over the period 2014-2019. The report, Global Mass Spectrometry Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, APAC and ROW; it also covers the landscape of the global mass spectrometry market and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market. There are signals that indicate that the market will witness a rise in mergers and acquisitions as well as partnerships between mass spectrometer companies and diagnostic companies in an effort to gain market share and develop awareness in the clinical communities regarding the products offered by such companies. According to the report, the use of these instruments in clinical sciences for preclinical tests of newfound drugs prior to their administration to humans has gained widespread popularity over the years. Further, the report states that as spectrometers are large and complex, they also use software for various measurement procedures. Therefore, companies need to invest heavily in providing training to their employees in how to use mass spectrometers effectively. To calculate the market size, the report considers revenue generated through various segments based on: - Types - Applications - Geography The market is divided into the following segments based on type: - Triple quadruple mass spectrometry - Time of flight mass spectrometry - MALDI-TOF mass spectrometry - Ion trap mass spectrometry - Fourier transform mass spectrometry - Single quadruple mass spectrometry The market is divided into the following segments based on application: - Biopharmaceuticals - Industrial Applications - Academia Key vendors - Agilent Technologies - Bruker - Danaher - Thermo Fisher Scientific - Waters Other prominent vendors - Bio-Rad Laboratories - Jeol - Perkin Elmer - Rigaku - Shimadzu For more information visit http://www.researchandmarkets.com/research/hk...lobal_mass
A: 38.27 (+0.94), DHR: 95.27 (+0.12)
Ametek Increases Share Repurchase Authorization by $350M
Zacks Equity Research - Zacks Investment Research - Wed Nov 11, 12:25PM CST
Ametek Inc. (AME) recently increased the share repurchase authorization by $350 million.
AME: 54.33 (-0.57), A: 38.27 (+0.94), GOOGL: 746.89 (-3.53), MXL: 16.31 (+0.42)
Complete Guide to Diagnostic Distribution in China - Profiles of all Three Types of Distribution Alternatives are Included in their Distribution Editions
M2 - Wed Nov 11, 4:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/txlwr5/complete_guide_to) has announced the addition of the "Complete Guide to Diagnostic Distribution in China" report to their offering. The Complete Guides to Diagnostic Distribution series are excerpts from their detailed market research studies. They are available for China, India, Brazil and Mexico. Distribution in all four countries is done by a mixture of international firms which also handle the products of other companies, by local manufacturers who add distribution of other product lines to their offerings and by local IVD distributors who put together a group of companies that do not have a local office. Profiles of all three types of distribution alternatives are included in their Distribution Editions. The full reports are sold to the top multinational diagnostic firms, but their Distribution Editions are designed for small to medium sized firms that are primarily interested in finding a distributor. They include a Country Summary section that reviews the healthcare system, private vs. public segmentation, medical insurance, the laboratory structure, product registration and any unusual features of the local market. Then there are the Profiles, divided into three sections: International Manufacturers, Domestic Manufactures and Domestic Distributors. Mexico is the one exception in that as a NAFTA country there is so little domestic manufacturing that the few firms that do some manufacturing are included under distributors. Key Topics Covered: 1. Country Summary 2. International Manufacturer Profiles 3. Domestic Manufacturer Profiles 4. Distributor Profiles Companies Mentioned - 3V Bioengineering - Abbott Laboratories - Accubio Tech - Acon Biotech - Adaltis - Addcare Bio-Tech - Advanced Clinical Laboratory Science (Acls) - Affymetrix - Agilent Technologies - Ai De Diagnostic (Ind) - Ailex Technology - Alere - Alt Biotech - Ausbio Laboratories - Bio-Asia Diagnostics - Biochem Group For more information visit http://www.researchandmarkets.com/research/tx...e_guide_to
ABT: 44.74 (-0.14), A: 38.27 (+0.94)
Future Horizons and Growth Strategies in the Global Beta-2 Microglobulin Testing Market 2016: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
M2 - Tue Nov 10, 10:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/6npmbs/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Beta-2 Microglobulin Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report to their offering. This report presents a detailed analysis of the ?-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion For more information visit http://www.researchandmarkets.com/research/6n...016_future
A: 38.27 (+0.94), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12)
Agilent's Mixed Q4 Report Yields Mixed Reactions
at Investor's Business Daily - 2 hrs 17 mins ago
Scientific instrument maker Agilent Technologies (A) opened down but quickly rose in heavy volume Tuesday after it beat Q4 estimates late Monday but offered guidance below consensus, leading to dueling analyst actions. For its fiscal Q4 ended Oct....
A: 38.27 (+0.94)
Agilent Technologies Beats Q4 Earnings, Matches Revenues
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 8:20AM CST
Agilent Technologies' (A) fiscal fourth-quarter 2015 earnings per share of 50 cents beat the Zacks Consensus Estimate by 3 cents and came above management's guidance range.
AMZN: 643.63 (-4.18), A: 38.27 (+0.94), TVPT: 13.73 (-0.03), STMP: 95.21 (-0.23)
Agilent Technologies (A) Earnings Report: Q4 2015 Conference Call Transcript
at The Street - Tue Nov 17, 7:15AM CST
The following Agilent Technologies (A) conference call took place on November 16, 2015, 04:30 PM ET. This is a transcript of that earnings call:
A: 38.27 (+0.94)
World Flow Cytometry Market Opportunities and Forecasts 2014-2022
M2 - Tue Nov 17, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/6sgk45/_world_flow) has announced the addition of the " World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022" report to their offering. The world flow cytometry market is estimated to reach $7.0 billion by 2022, registering a CAGR of 16.0% over the forecast period Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices. The flow cytometry technology is widely used in the various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV and hematological malignancies. Rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need of flow cytometry in the effective diagnosis and monitoring of diseases. World flow cytometry market is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics and marine biology would further supplement the market growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users and the limited availability of technical expertise are likely to impede the market growth. The preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 World Flow Cytometry Market, By Component, 2014-2022 Chapter 5 World Flow Cytometry Market, By Technology, 2014-2022 Chapter 6 World Flow Cytometry Market, By Application, 2014-2022 Chapter 7 World Flow Cytometry Market, By End User, 2014-2022 Chapter 8 World Flow Cytometry Market, By Geography, 2014-2022 Chapter 9 Company Profiles - Affymetrix Inc. - Becton - Bio-Rad Laboratories - Dako (Agilent Technologies) - Danaher Corporation (Beckman Coulter) - Dickinson and Co. - Luminex Corporation - Merck Millipore - Miltenyi Biotec GmbH. - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/6s...world_flow
A: 38.27 (+0.94), MRK: 53.66 (-0.04), LMNX: 20.71 (-0.03), DHR: 95.27 (+0.12), AFFX: 8.99 (+0.07)
Agilent Technologies Reports Fourth-Quarter 2015 Results
M2 - Tue Nov 17, 2:26AM CST
Highlights:
A: 38.27 (+0.94)
How Will Agilent Technologies (A) Stock React to Earnings Beat?
at The Street - Mon Nov 16, 3:42PM CST
After the market close, Agilent Technologies (A) reported 2015 fourth quarter earnings ahead of expectations, while revenue was in line with estimates.
A: 38.27 (+0.94)
U.S. Cancer Diagnostics Market 2016: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
M2 - Mon Nov 16, 10:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/74t673/2016_u_s_cancer) has announced the addition of the "2016 U.S. Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. This new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Business Opportunities and Strategic Recommendations - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. Market Segmentation Analysis - Sales and market shares of major suppliers, by individual cancer diagnostic test. Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including: - Hospitals - Commercial/Private Laboratories - Physician Offices/Group Practices - Cancer Clinics - Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers. - Cancer statistics, etiology and recent developments. Current and Emerging Products Review of over 200 current and emerging cancer diagnostic tests, including: - Biochemical Markers - Oncogenes - Growth Factors - Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains, and others. - Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/74...u_s_cancer
SQNM: 1.64 (-0.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), DGX: 67.96 (+0.45), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
Global Cancer Diagnostics Market 2016: Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers
M2 - Mon Nov 16, 10:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/8jj4mk/2016_global) has announced the addition of the "2016 Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers" report to their offering. This new report provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: - Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, UK and US - Marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others - Overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new technologies, products, and applications - Review of current instrumentation used for cancer diagnostic testing - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing - Competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy - Profiles of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/8j...016_global
MYGN: 43.45 (+1.03), A: 38.27 (+0.94), DGX: 67.96 (+0.45), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12)
2016 Global Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants
M2 - Mon Nov 16, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/l2f5q9/2016_global) has announced the addition of the "2016 Global Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants" report to their offering. This new report provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/l2...016_global
SQNM: 1.64 (-0.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), DGX: 67.96 (+0.45), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
World Beta-2 Microglobulin Testing Market Report 2016-2021 - Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies & Competitive Landscape
M2 - Mon Nov 16, 6:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/3zh7zg/2016_world_beta2) has announced the addition of the "2016 World Beta-2 Microglobulin Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-- US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. This report presents a detailed analysis of the ?-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco For more information visit http://www.researchandmarkets.com/research/3z...orld_beta2
MYGN: 43.45 (+1.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
2016-2021 World CA Tumor Markers Testing Market Report
M2 - Mon Nov 16, 6:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/z2jn8v/2016_world_ca) has announced the addition of the "2016 World CA Tumor Markers Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. This report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/z2...6_world_ca
SQNM: 1.64 (-0.03), A: 38.27 (+0.94), DGX: 67.96 (+0.45), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12)
2016 World CEA Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies & Competitive Landscape
M2 - Mon Nov 16, 6:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/ksfml4/2016_world_cea) has announced the addition of the "2016 World CEA Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Epigenomics - Enterix/Clinical Genomics - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/ks..._world_cea
SQNM: 1.64 (-0.03), MYGN: 43.45 (+1.03), ENZ: 4.65 (+0.31), A: 38.27 (+0.94), CPHD: 35.31 (+0.22), HOLX: 39.90 (+0.17)
2016 World Occult Blood Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape
M2 - Mon Nov 16, 6:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/htwtlc/2016_world_occult) has announced the addition of the "2016 World Occult Blood Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan" report to their offering. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. This report presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/ht...rld_occult
SQNM: 1.64 (-0.03), MYGN: 43.45 (+1.03), A: 38.27 (+0.94), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12), HOLX: 39.90 (+0.17)
Nov. 16 Premarket Briefing: Marriott to Buy Starwood
at The Street - Mon Nov 16, 6:00AM CST
U.S. stock futures rise Monday, while European stocks are mixed in choppy trading following the terrorist attacks in Paris on Friday that left at least 129 people dead.
GE: 30.02 (-0.34), CCL: 50.47 (-0.30), A: 38.27 (+0.94), PFE: 33.01 (-0.15), MAR: 73.36 (-0.36), HOT: 72.25 (-0.02), DDS: 72.96 (+0.44), URBN: 21.00 (-1.67), AGN: 296.11 (-2.60), ERIC: 9.48 (-0.06), CAT: 69.44 (-0.95), JD: 28.82 (+0.01), CSCO: 26.85 (+0.06)
What Lies Ahead for Agilent Technologies' (A) Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 12:40PM CST
Agilent Technologies Inc. (A) is set to report fourth-quarter fiscal 2015 results on Nov 16. Last quarter, the company posted a 7.32% positive earnings surprise.
STOR: 21.87 (+0.09), A: 38.27 (+0.94), SDLP: 10.69 (-0.44), SIG: 137.05 (-1.60)
Global Mass Spectrometry Market 2015-2019
M2 - Thu Nov 12, 8:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/hkntz7/global_mass) has announced the addition of the "Global Mass Spectrometry Market 2015-2019" report to their offering. The global mass spectrometry market to grow at a CAGR of 8.34% over the period 2014-2019. The report, Global Mass Spectrometry Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, APAC and ROW; it also covers the landscape of the global mass spectrometry market and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market. There are signals that indicate that the market will witness a rise in mergers and acquisitions as well as partnerships between mass spectrometer companies and diagnostic companies in an effort to gain market share and develop awareness in the clinical communities regarding the products offered by such companies. According to the report, the use of these instruments in clinical sciences for preclinical tests of newfound drugs prior to their administration to humans has gained widespread popularity over the years. Further, the report states that as spectrometers are large and complex, they also use software for various measurement procedures. Therefore, companies need to invest heavily in providing training to their employees in how to use mass spectrometers effectively. To calculate the market size, the report considers revenue generated through various segments based on: - Types - Applications - Geography The market is divided into the following segments based on type: - Triple quadruple mass spectrometry - Time of flight mass spectrometry - MALDI-TOF mass spectrometry - Ion trap mass spectrometry - Fourier transform mass spectrometry - Single quadruple mass spectrometry The market is divided into the following segments based on application: - Biopharmaceuticals - Industrial Applications - Academia Key vendors - Agilent Technologies - Bruker - Danaher - Thermo Fisher Scientific - Waters Other prominent vendors - Bio-Rad Laboratories - Jeol - Perkin Elmer - Rigaku - Shimadzu For more information visit http://www.researchandmarkets.com/research/hk...lobal_mass
A: 38.27 (+0.94), DHR: 95.27 (+0.12)
Ametek Increases Share Repurchase Authorization by $350M
Zacks Equity Research - Zacks Investment Research - Wed Nov 11, 12:25PM CST
Ametek Inc. (AME) recently increased the share repurchase authorization by $350 million.
AME: 54.33 (-0.57), A: 38.27 (+0.94), GOOGL: 746.89 (-3.53), MXL: 16.31 (+0.42)
Complete Guide to Diagnostic Distribution in China - Profiles of all Three Types of Distribution Alternatives are Included in their Distribution Editions
M2 - Wed Nov 11, 4:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/txlwr5/complete_guide_to) has announced the addition of the "Complete Guide to Diagnostic Distribution in China" report to their offering. The Complete Guides to Diagnostic Distribution series are excerpts from their detailed market research studies. They are available for China, India, Brazil and Mexico. Distribution in all four countries is done by a mixture of international firms which also handle the products of other companies, by local manufacturers who add distribution of other product lines to their offerings and by local IVD distributors who put together a group of companies that do not have a local office. Profiles of all three types of distribution alternatives are included in their Distribution Editions. The full reports are sold to the top multinational diagnostic firms, but their Distribution Editions are designed for small to medium sized firms that are primarily interested in finding a distributor. They include a Country Summary section that reviews the healthcare system, private vs. public segmentation, medical insurance, the laboratory structure, product registration and any unusual features of the local market. Then there are the Profiles, divided into three sections: International Manufacturers, Domestic Manufactures and Domestic Distributors. Mexico is the one exception in that as a NAFTA country there is so little domestic manufacturing that the few firms that do some manufacturing are included under distributors. Key Topics Covered: 1. Country Summary 2. International Manufacturer Profiles 3. Domestic Manufacturer Profiles 4. Distributor Profiles Companies Mentioned - 3V Bioengineering - Abbott Laboratories - Accubio Tech - Acon Biotech - Adaltis - Addcare Bio-Tech - Advanced Clinical Laboratory Science (Acls) - Affymetrix - Agilent Technologies - Ai De Diagnostic (Ind) - Ailex Technology - Alere - Alt Biotech - Ausbio Laboratories - Bio-Asia Diagnostics - Biochem Group For more information visit http://www.researchandmarkets.com/research/tx...e_guide_to
ABT: 44.74 (-0.14), A: 38.27 (+0.94)
Future Horizons and Growth Strategies in the Global Beta-2 Microglobulin Testing Market 2016: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
M2 - Tue Nov 10, 10:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/6npmbs/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Beta-2 Microglobulin Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report to their offering. This report presents a detailed analysis of the ?-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Companies Mentioned - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion For more information visit http://www.researchandmarkets.com/research/6n...016_future
A: 38.27 (+0.94), CPHD: 35.31 (+0.22), DHR: 95.27 (+0.12)
